Recombinant Mouse T-lymphocyte surface antigen Ly-9 Protein
PKSM041214
Regular price
$393.00
$318.00
You Pay
Supplier: Elabscience
Product Name: Recombinant Mouse T-lymphocyte surface antigen Ly-9 Protein
Catalog No. PKSM041214
Product Type: recombinant protein
Size: 50 ug
Activity:
Protein Construction: Recombinant Mouse T-lymphocyte surface antigen Ly-9 is produced by our Mammalian expression system and the target gene encoding Lys48-Phe454 is expressed with a 6His tag at the C-terminus.
Sequence: Met 1-Arg 453
Fusion Tag: C-6His
Accession: NP_032560.2
Species: Mouse
Expressed Host: Human Cells
Shipping Conditions: In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Purity: ?95% as determined by reducing SDS-PAGE.
Endotoxin: <1.0 EU per ?g as determined by LAL test.
Stability: Lyophilized protein should be stored at < -20?, though stable at room temperature for 3 weeks.Reconstituted protein solution can be stored at 4-7? for 2-7 days.Aliquots of reconstituted samples are stable at < -20? for 3 months
Molecular Weight: 47 kDa
Applied MM: 65-75 kDa
Formulation: Lyophilized from a 0.2 ?m filtered solution of PBS, pH7.4.
Reconstitution: Please refer to it for detailed information.
Background: CD229(SLAMF3) is a type I transmembrane glycoprotein in the SLAM subgroup of the CD2 family. Mature mouse CD229 consists of a 406 aa extracellular domain (ECD) with two Ig-like V-set and two Ig-like truncated C2-set domains, a 21 aa transmembrane segment, and a 180 aa cytoplasmic domain with two immunoreceptor tyrosinebased switch motifs ITSMs. Within the first two Ig-like domains that are common to all SLAM proteins, mouse CD229 shares 22%-36% aa sequence identity with mouse 2B4, BLAME, CD2F10,CD84, CRACC, NTBA, and SLAM. CD229 is expressed on T, B, and NK cells, thymocytes and monocytes. Homophilic binding between CD229 molecules is mediated by the N-terminal Ig-like domain. Human and mouse CD229 exhibit crossspecies binding. Antigen stimulation of lymphocytes induces CD229 clustering to sites of T cell-B cell contact. Antibody ligation of CD229 can inhibit T cell activation, but CD229 knockout mice show impaired T cell immune responses, suggesting a potential role for CD229 in T cell activation or costimulation.